Although prior reports have compared molecular signatures between adult CML CD34+ cells and healthy CD34+ cells [14,15], our study is the first to compare transcriptome profiles of CML CD34+ cells across different age groups. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.